- $31.90bn
- $39.00bn
- $9.47bn
Brief: Zoetis Says Co Priced Offering Of $1.75 Billion Aggregate Principal Amount Of 0.25% Convertible Senior Notes Due 2029
U.S. STOCKS ON THE MOVE-Brystol Myers, Nvidia
Zoetis climbs after unveiling $1.75 bln convertible offering for stock buybacks
U.S. STOCKS ON THE MOVE-Vanda Pharma, Tesla, Zillow
U.S. STOCKS ON THE MOVE-Micron Technology, Carvana, ServiceNow
Zoetis dips after unveiling $1.75 bln convertible for stock buybacks
Brief: Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering
Brief: Zoetis Declares First Quarter 2026 Dividend Board Approves 6% Payment Increase
U.S. RESEARCH ROUNDUP-JP Morgan, Pepsico, Pfizer
Brief: Zoetis Receives Health Canada Approval For Portela(Relfovetmab Injection)
Brief: Zoetis Receives European Commission Marketing Authorization For Lenivia (Izenivetmab) To Reduce Pain Associated With Osteoarthritis (OA) In Dogs
Elanco Animal Health rises as KeyBanc joins bull camp
U.S. RESEARCH ROUNDUP-Bath & Body Works, Elastic, Walmart
U.S. RESEARCH ROUNDUP- Bath & Body Works, Elastic, Walmart
U.S. STOCKS ON THE MOVE-Marriott, Leidos, McDonald's
Zoetis trims annual revenue forecast on muted demand for animal treatments, shares slide (updated)
U.S. STOCKS ON THE MOVE-Hims & Hers Health, Hertz Global, Metsera
Zoetis drops after cutting annual revenue forecast
U.S. STOCKS ON THE MOVE-Yum Brands, Waters, Harley-Davidson